BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30811816)

  • 1. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
    Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
    J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1
    Řehořová M; Vargová I; Forostyak S; Vacková I; Turnovcová K; Kupcová Skalníková H; Vodička P; Kubinová Š; Syková E; Jendelová P
    Stem Cells Transl Med; 2019 Jun; 8(6):535-547. PubMed ID: 30802001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Zhang C; Zhou C; Teng JJ; Zhao RL; Song YQ; Zhang C
    Cytotherapy; 2009; 11(3):299-306. PubMed ID: 19333801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
    Vercelli A; Mereuta OM; Garbossa D; Muraca G; Mareschi K; Rustichelli D; Ferrero I; Mazzini L; Madon E; Fagioli F
    Neurobiol Dis; 2008 Sep; 31(3):395-405. PubMed ID: 18586098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.
    Forostyak S; Jendelova P; Kapcalova M; Arboleda D; Sykova E
    Cytotherapy; 2011 Oct; 13(9):1036-46. PubMed ID: 21736505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.
    Sironi F; Vallarola A; Violatto MB; Talamini L; Freschi M; De Gioia R; Capelli C; Agostini A; Moscatelli D; Tortarolo M; Bigini P; Introna M; Bendotti C
    Stem Cell Res; 2017 Dec; 25():166-178. PubMed ID: 29154076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed onset, immunomodulation, and lifespan improvement of SOD1
    Chiarotto GB; Cartarozzi LP; Perez M; Tomiyama ALMR; de Castro MV; Duarte ASS; Luzo ÂCM; Oliveira ALR
    Brain Res Bull; 2022 Aug; 186():153-164. PubMed ID: 35718222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
    Uccelli A; Milanese M; Principato MC; Morando S; Bonifacino T; Vergani L; Giunti D; Voci A; Carminati E; Giribaldi F; Caponnetto C; Bonanno G
    Mol Med; 2012 Jul; 18(1):794-804. PubMed ID: 22481270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1
    Lee JD; McDonald TS; Fung JNT; Woodruff TM
    Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis.
    Zhou C; Zhang C; Zhao R; Chi S; Ge P; Zhang C
    J Neuroinflammation; 2013 Apr; 10():52. PubMed ID: 23631660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis.
    Boido M; Piras A; Valsecchi V; Spigolon G; Mareschi K; Ferrero I; Vizzini A; Temi S; Mazzini L; Fagioli F; Vercelli A
    Cytotherapy; 2014 Aug; 16(8):1059-72. PubMed ID: 24794182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
    Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
    Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.